Brian Park, PharmD

Drug Information Specialist https://www.clinicalpainadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

General Pain

ZTlido Labeling Updated With Clinical Data on Water Exposure

Brian Park, PharmD

April 19, 2021

The FDA has approved the sNDA for ZTlido, a lidocaine topical system, to include additional administration-related data.

doctor administering COVID19 nasal swab test

General Pain

Lucira Check It Test Kit Available OTC for At-Home COVID-19 Testing

Brian Park, PharmD

April 19, 2021

The Lucira Check It COVID-19 test kit utilizes a molecular amplification technology to detect SARS-CoV-2 RNA.

General Pain

Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients

Brian Park, PharmD

April 14, 2021

Findings showed that the trial did not meet statistical significance on the primary endpoint.

General Pain

Moderna COVID-19 Vaccine: Antibody Persistence Observed Through 6 Months After Second Dose

Brian Park, PharmD

April 14, 2021

The study analyzed 33 healthy adult participants in the National Institutes of Health (NIH)-led phase 1 study of the Moderna COVID-19 vaccine at 6 months following the second dose.

General Pain

Pfizer-BioNTech COVID-19 Vaccine Shows 100% Efficacy in Adolescents

Brian Park, PharmD

April 9, 2021

A phase 3 trial evaluating the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, in adolescent participants 12 to 15 years of age demonstrated 100% efficacy and strong antibody responses.

General Pain

COVID-19 Home Collection Antibody Test Gets Emergency Use Authorization

Brian Park, PharmD

April 9, 2021

The collected samples are sent to a Symbiotica, Inc laboratory for analysis.

Practice Management

FDA Launches Adverse Event Reporting Dashboard for Authorized COVID-19 Therapeutics

Brian Park, PharmD

March 19, 2021

The FDA has launched the FDA Adverse Event Reporting System (FAERS) Public Dashboard for COVID-19 Emergency Use Authorization products.

General Pain

Possible Sterility Breach Prompts Recall of Phenylephrine Hydrochloride Injection

Brian Park, PharmD

March 18, 2021

Sagent Pharmaceuticals is recalling 3 lots of Phenylephrine Hydrochloride Injection due to potentially loose crimped vial overseals.

Practice Management

Real-World Data Demonstrate Effectiveness of Pfizer-BioNTech COVID-19 Vaccine

Brian Park, PharmD

March 15, 2021

The analysis was conducted when more than 80% of tested specimens in Israel were variant B.1.1.7 (UK variant).

Practice Management

Flucelvax Quadrivalent Approval Expanded to Include Younger Patients

Brian Park, PharmD

March 12, 2021

Flucelvax Quadrivalent is a subunit influenza vaccine manufactured using cell derived candidate vaccine viruses; it does not contain egg proteins or antibiotics.

Next post in Practice Management